ADDEX THERAPEUTICS
Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators for neurological disorders. Its modulators offer several potential advantages over conventional non-allosteric molecules and may offer an improved therapeutic approach to conventional "orthosteric" small molecules or biological drugs. Its allosteric modulator drug discovery platform targets receptors and other proteins that are recognized as essential for therapeutic intervention.
ADDEX THERAPEUTICS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2002-01-01
Address:
Plan-les-ouates, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.addextherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+41228841555
Email Addresses:
[email protected]
Total Funding:
203.88 M USD
Technology used in webpage:
Apple Mobile Web Clips Icon Global Site Tag Google Universal Analytics Cloudflare JS ReCAPTCHA V2 Infomaniak Network
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Indivior
Indivior investment in Post-IPO Equity - Addex Therapeutics
Armistice Master Fund LTV
Armistice Master Fund LTV investment in Post-IPO Equity - Addex Therapeutics
Indivior
Indivior investment in Post-IPO Equity - Addex Therapeutics
Innosuisse
Innosuisse investment in Grant - Addex Therapeutics
National Institute on Drug Abuse (NIDA)
National Institute on Drug Abuse (NIDA) investment in Grant - Addex Therapeutics
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Addex Therapeutics
Hercules Bioventure Partners
Hercules Bioventure Partners investment in Post-IPO Equity - Addex Therapeutics
Michael J. Fox Foundation
Michael J. Fox Foundation investment in Grant - Addex Therapeutics
Hercules Bioventure Partners
Hercules Bioventure Partners investment in Post-IPO Equity - Addex Therapeutics
Armistice Capital
Armistice Capital investment in Post-IPO Equity - Addex Therapeutics
Official Site Inspections
http://www.addextherapeutics.com Semrush global rank: 4.03 M Semrush visits lastest month: 2.66 K
- Host name: od-d1e2fa.infomaniak.ch
- IP address: 83.166.152.52
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "Addex Therapeutics"
About us - Addex therapeutics
Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known …See details»
Overview - Addex therapeutics
Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders.See details»
Addex Therapeutics - Crunchbase Company Profile & Funding
Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known …See details»
Addex Therapeutics Ltd (ADXN) Company Profile & Facts - Yahoo …
Nov 22, 2024 Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The …See details»
Addex Therapeutics - LinkedIn
Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known …See details»
Addex Therapeutics Company Description - Stock Analysis
3 days ago Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The …See details»
Addex Therapeutics Ltd (ADXN) - Stock Analysis
Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on …See details»
Addex therapeutics - Overview, News & Similar companies
Jun 23, 2021 Addex Increases Issued Share Capital to Create Treasury Shares Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, February 3, 2022 - Addex …See details»
Addex Therapeutics - Craft
Oct 29, 2024 Addex Therapeutics, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for the treatment of …See details»
Addex Therapeutics - Overview, News & Similar companies
Founded in 2002, Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging clas s of novel orally available small …See details»
Addex Provides Corporate Update and Financial Guidance
Dec 31, 2022 Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available, small …See details»
addextherapeutics.com Reviews: Is this site a scam or legit?
Organization Domains By Proxy, LLC ... In the context of addextherapeutics.com, our investigation continues working to pinpoint the specific category, but we welcome your insights …See details»
Addex therapeutics :: Addex and Indivior Extend Research Term of ...
Dec 8, 2022 Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available, small …See details»
Addex therapeutics :: Addex and Indivior Select Clinical Candidates ...
Aug 27, 2024 For more information, visit www.addextherapeutics.com. Contacts: Tim Dyer Chief Executive Officer Telephone: +41 22 884 15 55 [email protected]. Mike Sinclair …See details»
Addex Provides Year End Pipeline Development Update
Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known …See details»
Addex therapeutics :: Addex Therapeutics Reports Full Year 2023 ...
Apr 18, 2024 Addex Therapeutics is a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders.See details»
Addex therapeutics :: Addex Reports Q3 2022 Financial Results and ...
Sep 30, 2022 Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available, small …See details»
Addex therapeutics :: Addex Therapeutics Reports Q1 2024 …
Jun 6, 2024 Addex Therapeutics is a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders.See details»
Pipeline - Addex therapeutics
Using an allosteric modulator platform and drug discovery and development expertise, we established a pipeline of clinical and preclinical programs. Click on CLINICAL AND PRE …See details»